Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-04-10 @ 9:32 AM
Study NCT ID:
NCT00531960
Status:
COMPLETED
Last Update Posted:
2014-11-11
First Post:
2007-09-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BO20571
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None